CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation Post author:Sam Post published:September 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like How Gilead Just Lost $9 Billion in Market Value This Week February 8, 2017 Zoetis To Host Webcast And Conference Call On Second Quarter 2017 Financial Results June 29, 2017 Sanofi Abandons Multiple Mid-Stage Drug Programs February 7, 2018